Importantly, a separate analysis of only Stage III and IV lung adenocarcinoma confirmed that patients with MYBL2 High tumors had significantly worse OS outcomes compared to patients with MYBL2 Low tumors (log-rank p = 7.9e–3, Figure 2E). Here, MYBL2 is linked to lung adenocarcinoma.